Warning: There are an increasing number of fraudulent websites that impersonate ECCMID. We would like to alert all our members and delegates to possible scams and we strongly advise you to use only the official ECCMID online registration and accommodation services for your bookings.

Meet-The-Expert Sessions

The Meet-the-Expert Sessions are led by recognized authorities in their fields. After a short presentation the experts will open the session for discussion, which will be driven by active audience participation.

Saturday 13 April 2019

8:45-9:45, Hall G
How to deal with antimicrobial drug and vaccine shortages?
co-organised with ESCMID Study Groups ESGAP and EVASG

Guillaume Beraud (Canada)
Larissa May (United States)

8:45-9:45, Hall L
How to manage and treat Crimean-Congo and other haemorrhagic fevers
co-organised with the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD)

Nurcan Baykam (Turkey)
Marta Mora-Rillo (Spain)

Sunday 14 April 2019

7:30-8:30, Hall F
Changing my laboratory: drivers and critical parameters of the process

Suzan D. Pas (Netherlands)
François Vandenesch (France)

7:30-8:30,Hall N
Making sense of genome shreds: tools and strategies for straightforward genome data analysis
co-organised with the ESCMID Study Groups ESGEM and ESGMD

David Aanensen (United Kingdom)
Natacha Couto (Netherlands)

7:30-8:30, Hall E
Decision-making in the detection and management of patients with sepsis and critical illness in resource-limited settings

Mervyn Mer (South Africa)
Heiman Wertheim (Netherlands)

7:30-8:30, Hall D
How to treat diabetic foot infections in view of new guidance?
co-organised with the Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK)

Mustafa B. Ertuğrul (Turkey)
Ilker Uçkay (Switzerland)

7:30-8:30, Hall G
Difficult treatment scenarios in transplant patients with opportunistic viral infections: a case-based approach

Nina Khanna (Switzerland)
Roy Chemaly (United States)

Monday 15 April 2019

7:30-8:30, Hall B
What I think should be the standard in diagnosing human mycoplasma infections
co-organised with the ESCMID Study Group ESGMAC

Cecile Bebear (France)
Jonas M. Winchell (United States)

7:30-8:30, Hall N
How to study, test and modulate microbiota before transfer/transplantation?
co-organised with ESCMID Study Groups ESGMD and ESGHAMI

Benjamin Davido (France)
Elisabeth Terveer (Netherlands)

7:30-8:30, Hall C
Difficulties to diagnose invasive fungal infection in paediatric patients
co-organised with the ESCMID Study Group EFISG

Elio Castagnola (Italy)
Thomas Lehrnbecher (Germany)

7:30-8:30, Hall E
EUCAST frequently asked questions
co-organised with the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Rafael Canton Moreno (Spain)
Erika Matuschek (Sweden)

7:30-8:30, Hall K
The Endocarditis Team: let's make it work!
co-organised with ESCMID Study Group ESGBIES

Susan Rehm (United States)
Siegbert Rieg (Germany)

7:30-8:30, Hall C
How to manage orthopaedic implant infection? Real-life clinical case discussion
co-organised with the ESCMID Study Group ESGIAI

Martin McNally (United Kingdom)
Marjan Wouthuyzen-Bakker (Netherlands)

7:30-8:30, Hall J
How to use Point-of-Care tests in microbiology: European versus USA experiences

Robin Patel (United States)
Maurizio Sanguinetti (Italy)

7:30-8:30, Hall G
How and when should PCR be used in the diagnosis of C. difficile infection?
co-organised with the ESCMID Study Group ESGCD

Ferric C. Fang (United States)
Maja Rupnik (Slovenia)

7:30-8:30, Hall D
How to implement effective antimicrobial stewardship measures in the era of MDR and XDR pathogens
co-organised with the Hellenic Society for Chemotherapy

Ana Gales (Brazil)
Maddalena Giannella (Italy)

Tuesday 16 April 2019

7:30-8:30, Hall M
Which host response assays are ready to get implemented in clinical practice?

Giovanni Delogu (Italy)
TBA

7:30-8:30, Hall C
What is needed for paving the way to HCV elimination?
co-organised with the European Association for the Study of the Liver (EASL)

Markus Cornberg (Germany)
Jean-Michel Pawlotsky (France

7:30-8:30, Hall J
Burning questions concerning the antimicrobial therapy of sepsis
co-organised with ESCMID Study Groups ESGAP and ESGBIES

Johan Mouton (Netherlands)
David L. Paterson (Australia)

7:30-8:30, Hall F
How to define fungal infection in critically ill patients: new ESCMID guidance?
co-organised with ESCMID Study Groups ESGCIP and EFISG

Matteo Bassetti (Italy)
Cornelia Lass-Flörl (Austria)

7:30-8:30, Hall G
How I manage vascular graft infection
co-organised with the ESCMID Study Group ESGIAI

Efthymia Giannitsioti (Greece)
Eric Senneville (France)

7:30-8:30, Hall D
How to implement and use metagenomics in infectious disease diagnostics and management?
co-organised with the Turkish Society of Clinical Microbiology

Koray Ergunay (Turkey)
Justin O'Grady (United Kingdom)

7:30-8:30, Hall B
How to best manage difficult-to-treat infectious diseases in migrants
co-organised with ESCMID Study Group ESGITM and the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD)

Susanna Capone (Italy)
Christian Wejse (Australia)

7:30-8:30, Hall E
How to manage immunocompromised patients with central nervous system infection?
co-organised with ESCMID Study Groups ESGBIES and ESGICH

Paola Cinque (Italy)
Oriol Manuel (Switzerland)